NL-OMON32507尚未招募不适用
The difference in fractional cholesterol absorption between subjects with high versus low plasma campesterol levels - DAHLIA-2
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male and female subjects, aged 18-65 years old, with an LDL-cholesterol concentration between 3.0 and 5.0 mmol/l, who participated in the Dahlia-1 study and belong to the 6 subjects with the highest or to the 6 subjects with the lowest plasma campesterol levels respectively. One subject with the subsequently highest campesterol levels will be asked to undergo a cholesterolabsorption measurement as well, in order for us to test the quantification of cholesterol isotopes by our laboratory.
排除标准
- •Excluded are persons with a genetic hyperlipoproteinemia like familial hypercholesterolemia, LPL-deficiency, familial dysbeta lipoproteinemia and familial hypertriglyceridemia. Also people with diabetes mellitus, severe hypertriglyceridemia, uncontrolled hypertension or history of arterial disease including unstable angina, myocardial infarction, recent transient ischaemic attacks or a cerebro-vascular accident, will be excluded.
研究者
相似试验
已完成
4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease HypercholesterolemiaJPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50
已完成
4 期
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSoundpatients aged 30-85 years who were undergoing percutaneous coronary intervention (PCI, elective or emergency) with >=1 significant stenosis >=75% and >=1 untouched nonculprit lesion of <=50% stenosis that could be imaged by intravascular ultrasound, and either LDL-C >=100 mg/dl.JPRN-UMIN000002959Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University300
已完成
不适用
The study about the effects of cholesterol absorption inhibition on coronary artery plaque in patients treated with PCIcoronary artery diseasesJPRN-UMIN000026581Kurume University Medical Center50
尚未招募
不适用
Validation of cholesterol absorption as measured by the dual isotope methodmild hypercholesterolemiaslightly elevated cholesterol10013317NL-OMON34258Academisch Medisch Centrum7
已完成
不适用
Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseasesJPRN-UMIN000030635Osaka City University3,000